Twist Bioscience Corporation, A Company Enabling Customers To Succeed Through Its Offering Of High-Quality Synthetic Dna Using Its Silicon Platform, And Medisix Therapeutics, A Cell Therapy Company Creating Novel Therapeutics To Target T-Cell Leukemia And Lymphoma, Today Announced A Collaboration To Discover Novel Antibodies Against Five Undisclosed Targets.Under The Terms Of The Collaboration, Twist Will Leverage Its Proprietary Library Of Libraries To Discover Five Novel Antibodies Directed Against Medisix
